Agency Forms Undergoing Paperwork Reduction Act Review, 34589-34590 [2018-15526]
Download as PDF
<![CDATA[
34589
Federal Register / Vol. 83, No. 140 / Friday, July 20, 2018 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Type of respondents
Form name
Patients aged 18 years or older .....................
Patients aged 18 years or older who completed 18 mo survey.
Patients aged 18 years or older who did not
complete 18 mo survey.
Online surveys (18-month follow-up) .............
Online surveys (30-month follow-up) .............
960
660
1
1
7/60
10/60
Online surveys (30-month follow-up) .............
220
1
10/60
Jeffrey M. Zirger,
Acting Chief, Information Collection Review
Office, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2018–15524 Filed 7–19–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–18–1091]
daltland on DSKBBV9HB2PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Using
Qualitative Methods to Understand
Issues in HIV Prevention, Care and
Treatment in the United States’’ to the
Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on March 13, 2018 to obtain
comments from the public and affected
agencies. CDC received four comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
VerDate Sep<11>2014
18:06 Jul 19, 2018
Jkt 244001
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
Using Qualitative Methods to
Understand Issues in HIV Prevention,
Care and Treatment in the United States
(OMB No. 0920–1091; expires December
31, 2018)—Extension—National Center
for HIV/AIDS, Viral Hepatitis, STD, and
TB Prevention, Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The CDC’s National Center on HIV/
AIDS, Viral Hepatitis, STD and TB
Prevention (NCHHSTP), Division of
HIV/AIDS Prevention (DHAP) seeks a
three year extension for an existing
Generic information collection request
(Generic ICR) entitled, ‘‘Using
Qualitative Methods to Understand
Issues in HIV Prevention, Care and
Treatment in the United States’’ (OMB
Number: 0920–1091). Specific studies
conducted under this extended Generic
ICR will be consistent with the national
HIV prevention goals, the CDC Division
of HIV/AIDS Prevention (DHAP)
Strategic Plan, and DHAP’s High-impact
HIV Prevention approach.
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
The purposes for each data collection
study supported under this extended
Generic ICR will be to understand
specific barriers and facilitators to local
HIV prevention, care and treatment in
the United States and territories. For
example, each study will seek to
identify ways to improve programmatic
activities along the continuum of HIV
prevention, treatment and care for
different populations residing in
different geographic settings with
greatest burden of HIV.
The target populations for studies
included in this extended Generic ICR
include, but are not limited to: Persons
living with HIV who are in treatment;
persons living with HIV who are out of
treatment and who may or may not be
seeking treatment at healthcare
facilities; persons at high risk for HIV
acquisition (HIV negative) and HIV
transmission (HIV positive); persons
from groups at high risk for HIV
including gay, bisexual and other MSM,
transgender persons, and injection and
non-injection drug users; persons from
racial and ethnic minorities; and
healthcare providers or other
professionals who provide HIV
prevention, care and treatment services.
Other populations may include
individuals who provide non-HIV
services or otherwise interact with
persons living with HIV or persons at
risk for HIV acquisition.
Studies will only provide local
contextual information about the
barriers and facilitators to HIV
prevention, care, and treatment
experienced by specific communities at
risk for acquiring HIV infection, by HIVpositive persons across the HIV care
continuum, and by organizations or
individuals providing HIV prevention,
care, treatment, and related support
services.
Data collection methods used in any
of the specific studies primarily will
consist of rapid qualitative assessment
methodologies, such as semi-structured
and in-depth qualitative interviews,
focus groups; direct observations;
document reviews; and short structured
surveys. Data will be analyzed using
E:\FR\FM\20JYN1.SGM
20JYN1
34590
Federal Register / Vol. 83, No. 140 / Friday, July 20, 2018 / Notices
well-established qualitative analysis
methods, such as coding interviews for
themes about barriers and successes to
HIV prevention, care, and treatment.
Structured response surveys will be
analyzed using descriptive statistics and
other appropriate statistical methods.
CDC will use the results from each
specific data collection study to help to
identify ways to improve local
programmatic activities for specific
communities along the continuum of
HIV prevention, treatment and care for
populations and areas with the greatest
HIV burden. CDC will communicate
study outcomes to local stakeholders
and organizations in positions to
consider and implement site-specific
improvements in HIV prevention, care,
and treatment for each of the study sites
examined. For stakeholders,
organizations, or agencies outside the
local affected communities, all
communications will include clear
discussion of the limitations of the
region-specific, qualitative methods and
the non-generalizability of the study
outcomes.
For a given year, each separate data
collection will range from 30
(minimum) to 200 (maximum)
respondents based on the nature and
scope of the research purposes. For
example, if there are three data
collections, the maximum combined
number of expected respondents is 600.
In a given year, CDC anticipates that the
need to screen 1600 persons to identify
800 eligible persons, of which 600
persons will agree to participate.
CDC anticipates that screener forms
will take five minutes to complete each,
contact information forms will take one
Type of respondents
General
General
General
General
General
General
General
Public—Adults
Public—Adults
Public—Adults
Public—Adults
Public—Adults
Public—Adults
Public—Adults
Jeffrey M. Zirger,
Acting Chief, Information Collection Review
Office, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2018–15526 Filed 7–19–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
daltland on DSKBBV9HB2PROD with NOTICES
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
18:06 Jul 19, 2018
Jkt 244001
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled ‘‘Surveillance of Nonfatal Injuries
Among On-Duty Law Enforcement
Officers.’’ The purpose of this project is
to collect follow-back telephone
interview data from injured and
exposed law enforcement officers
treated in emergency departments (EDs)
and produce a descriptive summary of
these injuries and exposures.
CDC must receive written
comments on or before September 18,
2018.
Proposed Data Collection Submitted
for Public Comment and
Recommendations
VerDate Sep<11>2014
Study Screener ..............................................
Contact Information Form ..............................
Consent Form ................................................
Demographic Survey ......................................
Interview Guide ..............................................
Provider Demographic Survey .......................
Provider Interview Guide ................................
DATES:
[60Day–2018–18APJ; Docket No. CDC–
2018–0062]
SUMMARY:
Number of
respondents
Form name
...................................
...................................
...................................
...................................
...................................
...................................
...................................
minute to complete each, and consent
forms will take five minutes to complete
each. CDC anticipates 50% of the
targeted populations screened will be
eligible for the study. Of eligible
persons, 75% will agree to participate.
Brief structured surveys will take 15
minutes to complete. In-depth
interviews or focus groups with
respondents are expected to take 60
minutes (one hour) to complete. Indepth interviews or focus groups with
healthcare providers are expected to
take 45 minutes to complete.
The total annual response burden
based on an average of 600 study
respondents per year (assuming three
large data collections involving 200
participants each) is estimated at 918
hours. There is no cost to respondents
other than their time.
You may submit comments,
identified by Docket No. CDC–2018–
0062 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
ADDRESSES:
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
1600
600
600
500
500
100
100
Number of
responses per
respondent
1
1
1
1
1
1
1
Average
burden per
response
(in hours)
5/60
1/60
5/60
15/60
1
15/60
45/60
change, all relevant comments to
Regulations.gov.
Please note: Submit all Federal
comments through the Federal
eRulemaking portal (regulations.gov) or
by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
E:\FR\FM\20JYN1.SGM
20JYN1
]]>Agencies
[Federal Register Volume 83, Number 140 (Friday, July 20, 2018)]
[Notices]
[Pages 34589-34590]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-15526]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-18-1091]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Using Qualitative Methods to Understand
Issues in HIV Prevention, Care and Treatment in the United States'' to
the Office of Management and Budget (OMB) for review and approval. CDC
previously published a ``Proposed Data Collection Submitted for Public
Comment and Recommendations'' notice on March 13, 2018 to obtain
comments from the public and affected agencies. CDC received four
comments related to the previous notice. This notice serves to allow an
additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide
written comments within 30 days of notice publication.
Proposed Project
Using Qualitative Methods to Understand Issues in HIV Prevention,
Care and Treatment in the United States (OMB No. 0920-1091; expires
December 31, 2018)--Extension--National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention, Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The CDC's National Center on HIV/AIDS, Viral Hepatitis, STD and TB
Prevention (NCHHSTP), Division of HIV/AIDS Prevention (DHAP) seeks a
three year extension for an existing Generic information collection
request (Generic ICR) entitled, ``Using Qualitative Methods to
Understand Issues in HIV Prevention, Care and Treatment in the United
States'' (OMB Number: 0920-1091). Specific studies conducted under this
extended Generic ICR will be consistent with the national HIV
prevention goals, the CDC Division of HIV/AIDS Prevention (DHAP)
Strategic Plan, and DHAP's High-impact HIV Prevention approach.
The purposes for each data collection study supported under this
extended Generic ICR will be to understand specific barriers and
facilitators to local HIV prevention, care and treatment in the United
States and territories. For example, each study will seek to identify
ways to improve programmatic activities along the continuum of HIV
prevention, treatment and care for different populations residing in
different geographic settings with greatest burden of HIV.
The target populations for studies included in this extended
Generic ICR include, but are not limited to: Persons living with HIV
who are in treatment; persons living with HIV who are out of treatment
and who may or may not be seeking treatment at healthcare facilities;
persons at high risk for HIV acquisition (HIV negative) and HIV
transmission (HIV positive); persons from groups at high risk for HIV
including gay, bisexual and other MSM, transgender persons, and
injection and non-injection drug users; persons from racial and ethnic
minorities; and healthcare providers or other professionals who provide
HIV prevention, care and treatment services. Other populations may
include individuals who provide non-HIV services or otherwise interact
with persons living with HIV or persons at risk for HIV acquisition.
Studies will only provide local contextual information about the
barriers and facilitators to HIV prevention, care, and treatment
experienced by specific communities at risk for acquiring HIV
infection, by HIV-positive persons across the HIV care continuum, and
by organizations or individuals providing HIV prevention, care,
treatment, and related support services.
Data collection methods used in any of the specific studies
primarily will consist of rapid qualitative assessment methodologies,
such as semi-structured and in-depth qualitative interviews, focus
groups; direct observations; document reviews; and short structured
surveys. Data will be analyzed using
[[Page 34590]]
well-established qualitative analysis methods, such as coding
interviews for themes about barriers and successes to HIV prevention,
care, and treatment. Structured response surveys will be analyzed using
descriptive statistics and other appropriate statistical methods.
CDC will use the results from each specific data collection study
to help to identify ways to improve local programmatic activities for
specific communities along the continuum of HIV prevention, treatment
and care for populations and areas with the greatest HIV burden. CDC
will communicate study outcomes to local stakeholders and organizations
in positions to consider and implement site-specific improvements in
HIV prevention, care, and treatment for each of the study sites
examined. For stakeholders, organizations, or agencies outside the
local affected communities, all communications will include clear
discussion of the limitations of the region-specific, qualitative
methods and the non-generalizability of the study outcomes.
For a given year, each separate data collection will range from 30
(minimum) to 200 (maximum) respondents based on the nature and scope of
the research purposes. For example, if there are three data
collections, the maximum combined number of expected respondents is
600. In a given year, CDC anticipates that the need to screen 1600
persons to identify 800 eligible persons, of which 600 persons will
agree to participate.
CDC anticipates that screener forms will take five minutes to
complete each, contact information forms will take one minute to
complete each, and consent forms will take five minutes to complete
each. CDC anticipates 50% of the targeted populations screened will be
eligible for the study. Of eligible persons, 75% will agree to
participate.
Brief structured surveys will take 15 minutes to complete. In-depth
interviews or focus groups with respondents are expected to take 60
minutes (one hour) to complete. In-depth interviews or focus groups
with healthcare providers are expected to take 45 minutes to complete.
The total annual response burden based on an average of 600 study
respondents per year (assuming three large data collections involving
200 participants each) is estimated at 918 hours. There is no cost to
respondents other than their time.
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
General Public--Adults................ Study Screener.......... 1600 1 5/60
General Public--Adults................ Contact Information Form 600 1 1/60
General Public--Adults................ Consent Form............ 600 1 5/60
General Public--Adults................ Demographic Survey...... 500 1 15/60
General Public--Adults................ Interview Guide......... 500 1 1
General Public--Adults................ Provider Demographic 100 1 15/60
Survey.
General Public--Adults................ Provider Interview Guide 100 1 45/60
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Acting Chief, Information Collection Review Office, Office of
Scientific Integrity, Office of the Associate Director for Science,
Office of the Director, Centers for Disease Control and Prevention.
[FR Doc. 2018-15526 Filed 7-19-18; 8:45 am]
BILLING CODE 4163-18-P
